Zhong Chen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Oxidative Stress

Pulmonary Fibrosis

Nitric Oxide Synthase

Top Venues

Oxidative medicine and cellular longevity

Journal of immunology research

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Dongxu Lin, Changcheng Luo, Pengyu Wei, An Zhang, Mengyang Zhang, Xiaoliang Wu, Bolang Deng, Zhipeng Li, Kai Cui, Zhong Chen
YAP1 Recognizes Inflammatory and Mechanical Cues to Exacerbate Benign Prostatic Hyperplasia via Promoting Cell Survival and Fibrosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Mengyang Zhang, Dongxu Lin, Changcheng Luo, Pengyu Wei, Kai Cui, Zhong Chen
Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way. Oxidative medicine and cellular longevity 2022 (2022)
Dongxu Lin, Mengyang Zhang, Changcheng Luo, Pengyu Wei, Kai Cui, Zhong Chen
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis. Journal of immunology research 2022 (2022)
Mengyang Zhang, Changcheng Luo, Dongxu Lin, Kai Cui, Zhong Chen, Jihong Liu
Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates. Oxidative medicine and cellular longevity 2021 (2021)
Yang Luan, Kai Cui, Zhe Tang, Yajun Ruan, Kang Liu, Tao Wang, Zhong Chen, Shao-Gang Wang, Ji-Hong Liu
Human Tissue Kallikrein 1 Improves Erectile Dysfunction of Streptozotocin-Induced Diabetic Rats by Inhibition of Excessive Oxidative Stress and Activation of the PI3K/AKT/eNOS Pathway. Oxidative medicine and cellular longevity 2020 (2020)